{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:47:14Z","timestamp":1790214434346,"version":"4.1.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2023QH113"],"award-info":[{"award-number":["ZR2023QH113"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074093"],"award-info":[{"award-number":["82074093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC140"],"award-info":[{"award-number":["2023RC140"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Administration of Traditional Chinese Medicine Science and Technology Department- Zhejiang Provincial Administration of Traditional Chinese Medicine","award":["GZY-ZJ-SY-2402"],"award-info":[{"award-number":["GZY-ZJ-SY-2402"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01632-z","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T12:52:17Z","timestamp":1743079937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Calcium channels as pharmacological targets for cancer therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Xiaozhen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"1632_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrc.2017.18","volume":"17","author":"GR Monteith","year":"2017","unstructured":"Monteith GR, Prevarskaya N, Roberts-Thomson SJ. The calcium-cancer signalling nexus. Nat Rev Cancer. 2017;17:367\u201380.","journal-title":"Nat Rev Cancer"},{"key":"1632_CR2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","volume":"33","author":"S Zheng","year":"2023","unstructured":"Zheng S, Wang X, Zhao D, Liu H, Hu Y. Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications. Trends Cell Biol. 2023;33:312\u201323.","journal-title":"Trends Cell Biol"},{"key":"1632_CR3","doi-asserted-by":"crossref","first-page":"103995","DOI":"10.1016\/j.drudis.2024.103995","volume":"29","author":"L Zhang","year":"2024","unstructured":"Zhang L, Ren C, Liu J, Huang S, Wu C, Zhang J. Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatment. Drug Discov Today. 2024;29:103995.","journal-title":"Drug Discov Today"},{"key":"1632_CR4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/HJH.0000000000003487","volume":"41","author":"R Jesus","year":"2023","unstructured":"Jesus R, Araujo FA, Alves QL, Dourado KC, Silva DF. Targeting temperature-sensitive transient receptor potential channels in hypertension: far beyond the perception of hot and cold. J Hypertens. 2023;41:1351\u201370.","journal-title":"J Hypertens"},{"key":"1632_CR5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/biom11071019","volume":"11","author":"T Karki","year":"2021","unstructured":"Karki T, Tojkander S. TRPV protein family-from mechanosensing to cancer invasion. Biomolecules. 2021;11:1019.","journal-title":"Biomolecules"},{"key":"1632_CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fphys.2019.00757","volume":"10","author":"J Canales","year":"2019","unstructured":"Canales J, Morales D, Blanco C, Rivas J, Diaz N, Angelopoulos I, Cerda O. A TR(i)P to cell migration: new roles of TRP channels in mechanotransduction and cancer. Front Physiol. 2019;10:757.","journal-title":"Front Physiol"},{"key":"1632_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature14367","volume":"520","author":"CE Paulsen","year":"2015","unstructured":"Paulsen CE, Armache JP, Gao Y, Cheng Y, Julius D. Structure of the TRPA1 ion channel suggests regulatory mechanisms. Nature. 2015;520:511\u20137.","journal-title":"Nature"},{"key":"1632_CR8","doi-asserted-by":"crossref","first-page":"16102","DOI":"10.1074\/jbc.RA118.005066","volume":"293","author":"F Sierra-Valdez","year":"2018","unstructured":"Sierra-Valdez F, Azumaya CM, Romero LO, Nakagawa T, Cordero-Morales JF. Structure-function analyses of the ion channel TRPC3 reveal that its cytoplasmic domain allosterically modulates channel gating. J Biol Chem. 2018;293:16102\u201314.","journal-title":"J Biol Chem"},{"key":"1632_CR9","doi-asserted-by":"crossref","unstructured":"Won J, Kim J, Kim J, Ko J, Park CH, Jeong B, Lee SE, Jeong H, Kim SH, Park H, So I, Lee HH. Cryo-EM structure of the heteromeric TRPC1\/TRPC4 channel. Nat Struct Mol Biol. 2024","DOI":"10.2210\/pdb8wpl\/pdb"},{"key":"1632_CR10","doi-asserted-by":"crossref","first-page":"e63429","DOI":"10.7554\/eLife.63429","volume":"10","author":"K Song","year":"2021","unstructured":"Song K, Wei M, Guo W, Quan L, Kang Y, Wu JX, Chen L. Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife. 2021;10:e63429.","journal-title":"Elife"},{"key":"1632_CR11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41422-018-0038-2","volume":"28","author":"Q Tang","year":"2018","unstructured":"Tang Q, Guo W, Zheng L, Wu JX, Liu M, Zhou X, Zhang X, Chen L. Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. Cell Res. 2018;28:746\u201355.","journal-title":"Cell Res"},{"key":"1632_CR12","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-023-38162-9","volume":"14","author":"A Neuberger","year":"2023","unstructured":"Neuberger A, Oda M, Nikolaev YA, Nadezhdin KD, Gracheva EO, Bagriantsev SN, Sobolevsky AI. Human TRPV1 structure and inhibition by the analgesic SB-366791. Nat Commun. 2023;14:2451.","journal-title":"Nat Commun"},{"key":"1632_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41589-022-01166-5","volume":"19","author":"J Fan","year":"2023","unstructured":"Fan J, Hu L, Yue Z, Liao D, Guo F, Ke H, Jiang D, Yang Y, Lei X. Structural basis of TRPV3 inhibition by an antagonist. Nat Chem Biol. 2023;19:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"1632_CR14","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/s41467-023-39346-z","volume":"14","author":"KD Nadezhdin","year":"2023","unstructured":"Nadezhdin KD, Talyzina IA, Parthasarathy A, Neuberger A, Zhang DX, Sobolevsky AI. Structure of human TRPV4 in complex with GTPase RhoA. Nat Commun. 2023;14:3733.","journal-title":"Nat Commun"},{"key":"1632_CR15","doi-asserted-by":"crossref","first-page":"eabe1508","DOI":"10.1126\/sciadv.abe1508","volume":"6","author":"R Bhardwaj","year":"2020","unstructured":"Bhardwaj R, Lindinger S, Neuberger A, Nadezhdin KD, Singh AK, Cunha MR, Derler I, Gyimesi G, Reymond JL, Hediger MA, Romanin C, Sobolevsky AI. Inactivation-mimicking block of the epithelial calcium channel TRPV6. Sci Adv. 2020;6:eabe1508.","journal-title":"Sci Adv"},{"key":"1632_CR16","doi-asserted-by":"crossref","first-page":"e50175","DOI":"10.7554\/eLife.50175","volume":"8","author":"Y Huang","year":"2019","unstructured":"Huang Y, Roth B, Lu W, Du J. Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel. Elife. 2019;8:e50175.","journal-title":"Elife"},{"key":"1632_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.aar4510","volume":"359","author":"HE Autzen","year":"2018","unstructured":"Autzen HE, Myasnikov AG, Campbell MG, Asarnow D, Julius D, Cheng Y. Structure of the human TRPM4 ion channel in a lipid nanodisc. Science. 2018;359:228\u201332.","journal-title":"Science"},{"key":"1632_CR18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s42003-023-05425-6","volume":"6","author":"S Palchevskyi","year":"2023","unstructured":"Palchevskyi S, Czarnocki-Cieciura M, Vistoli G, Gervasoni S, Nowak E, Beccari AR, Nowotny M, Talarico C. Structure of human TRPM8 channel. Commun Biol. 2023;6:1065.","journal-title":"Commun Biol"},{"key":"1632_CR19","doi-asserted-by":"crossref","first-page":"2341077","DOI":"10.1080\/19336950.2024.2341077","volume":"18","author":"M Trus","year":"2024","unstructured":"Trus M, Atlas D. Non-ionotropic voltage-gated calcium channel signaling. Channels (Austin). 2024;18:2341077.","journal-title":"Channels (Austin)"},{"key":"1632_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1570159X20666220327211156","volume":"21","author":"B Correa","year":"2023","unstructured":"Correa B, Moreira CR, Hildebrand ME, Vieira LB. The role of voltage-gated calcium channels in basal ganglia neurodegenerative disorders. Curr Neuropharmacol. 2023;21:183\u2013201.","journal-title":"Curr Neuropharmacol"},{"key":"1632_CR21","doi-asserted-by":"crossref","first-page":"20041","DOI":"10.1074\/jbc.M109.013326","volume":"284","author":"DB Halling","year":"2009","unstructured":"Halling DB, Georgiou DK, Black DJ, Yang G, Fallon JL, Quiocho FA, Pedersen SE, Hamilton SL. Determinants in CaV1 channels that regulate the Ca2+ sensitivity of bound calmodulin. J Biol Chem. 2009;284:20041\u201351.","journal-title":"J Biol Chem"},{"key":"1632_CR22","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/s41467-024-47116-8","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Yu Z, Wang L, Li X, Li N, Bai Q, Wang Y, Li R, Meng Y, Xu H, Wang X, Dong Y, Huang Z, Zhang XC, Zhao Y. Structural bases of inhibitory mechanism of Ca(V)1.2 channel inhibitors. Nat Commun. 2024;15:2772.","journal-title":"Nat Commun"},{"key":"1632_CR23","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41422-022-00663-5","volume":"32","author":"X Yao","year":"2022","unstructured":"Yao X, Gao S, Yan N. Structural basis for pore blockade of human voltage-gated calcium channel Ca(v)1.3 by motion sickness drug cinnarizine. Cell Res. 2022;32:946\u20138.","journal-title":"Cell Res"},{"key":"1632_CR24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41422-024-00940-5","volume":"34","author":"Z Li","year":"2024","unstructured":"Li Z, Cong Y, Wu T, Wang T, Lou X, Yang X, Yan N. Structural basis for different omega-agatoxin IVA sensitivities of the P-type and Q-type Ca(v)2.1 channels. Cell Res. 2024;34:455\u20137.","journal-title":"Cell Res"},{"key":"1632_CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-021-03699-6","volume":"596","author":"S Gao","year":"2021","unstructured":"Gao S, Yao X, Yan N. Structure of human Ca(v)2.2 channel blocked by the painkiller ziconotide. Nature. 2021;596:143\u20137.","journal-title":"Nature"},{"key":"1632_CR26","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1038\/s41467-022-35026-6","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao X, Wang Y, Wang Z, Fan X, Wu D, Huang J, Mueller A, Gao S, Hu M, Robinson CV, Yu Y, Gao S, Yan N. Structures of the R-type human Ca(v)2.3 channel reveal conformational crosstalk of the intracellular segments. Nat Commun. 2022;13:7358.","journal-title":"Nat Commun"},{"key":"1632_CR27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-019-1801-3","volume":"576","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Huang G, Wu Q, Wu K, Li R, Lei J, Pan X, Yan N. Cryo-EM structures of apo and antagonist-bound human Ca(v)3.1. Nature. 2019;576:492\u20137.","journal-title":"Nature"},{"key":"1632_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41422-024-00959-8","volume":"34","author":"J Huang","year":"2024","unstructured":"Huang J, Fan X, Jin X, Lyu C, Guo Q, Liu T, Chen J, Davakan A, Lory P, Yan N. Structural basis for human Ca(v)3.2 inhibition by selective antagonists. Cell Res. 2024;34:440\u201350.","journal-title":"Cell Res"},{"key":"1632_CR29","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41467-022-29728-0","volume":"13","author":"L He","year":"2022","unstructured":"He L, Yu Z, Geng Z, Huang Z, Zhang C, Dong Y, Gao Y, Wang Y, Chen Q, Sun L, Ma X, Huang B, Wang X, Zhao Y. Structure, gating, and pharmacology of human Ca(V)3.3 channel. Nat Commun. 2022;13:2084.","journal-title":"Nat Commun"},{"key":"1632_CR30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/biom14091139","volume":"14","author":"A Shteinfer-Kuzmine","year":"2024","unstructured":"Shteinfer-Kuzmine A, Santhanam M, Shoshan-Barmatz V. VDAC1-based peptides as potential modulators of VDAC1 interactions with its partners and as a therapeutic for cancer, NASH, and diabetes. Biomolecules. 2024;14:1139.","journal-title":"Biomolecules"},{"key":"1632_CR31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/biom10111485","volume":"10","author":"V Shoshan-Barmatz","year":"2020","unstructured":"Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A. VDAC1 at the intersection of cell metabolism, apoptosis, and diseases. Biomolecules. 2020;10:1485.","journal-title":"Biomolecules"},{"key":"1632_CR32","doi-asserted-by":"crossref","unstructured":"Wang J, Jiang J, Hu H, Chen L. MCU complex: exploring emerging targets and mechanisms of mitochondrial physiology and pathology. J Adv Res. 2024","DOI":"10.1016\/j.jare.2024.02.013"},{"key":"1632_CR33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1080\/15384101.2019.1612698","volume":"18","author":"S Marchi","year":"2019","unstructured":"Marchi S, Vitto V, Danese A, Wieckowski MR, Giorgi C, Pinton P. Mitochondrial calcium uniporter complex modulation in cancerogenesis. Cell Cycle. 2019;18:1068\u201383.","journal-title":"Cell Cycle"},{"key":"1632_CR34","doi-asserted-by":"crossref","first-page":"e23454","DOI":"10.1096\/fj.202301368RR","volume":"38","author":"VM Ramos","year":"2024","unstructured":"Ramos VM, Serna J, Vilas-Boas EA, Cabral-Costa JV, Cunha FM, Kataura T, Korolchuk VI, Kowaltowski AJ. Mitochondrial sodium\/calcium exchanger (NCLX) regulates basal and starvation-induced autophagy through calcium signaling. FASEB J. 2024;38:e23454.","journal-title":"FASEB J"},{"key":"1632_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41419-022-04668-1","volume":"13","author":"V Tangeda","year":"2022","unstructured":"Tangeda V, Lo YK, Babuharisankar AP, Chou HY, Kuo CL, Kao YH, Lee AY, Chang JY. Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca(2+) release in cancer cells. Cell Death Dis. 2022;13:241.","journal-title":"Cell Death Dis"},{"key":"1632_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ceca.2018.04.006","volume":"73","author":"MJ Novello","year":"2018","unstructured":"Novello MJ, Zhu J, Feng Q, Ikura M, Stathopulos PB. Structural elements of stromal interaction molecule function. Cell Calcium. 2018;73:88\u201394.","journal-title":"Cell Calcium"},{"key":"1632_CR37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.32471\/exp-oncology.2312-8852.vol-41-no-3.13473","volume":"41","author":"YM Shuba","year":"2019","unstructured":"Shuba YM. Ca(2+) channel-forming ORAI proteins: cancer foes or cancer allies? Exp Oncol. 2019;41:200\u20136.","journal-title":"Exp Oncol"},{"key":"1632_CR38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/gpb_2020040","volume":"40","author":"J Wang","year":"2021","unstructured":"Wang J, Zhao W, Wang X, Gao H, Liu R, Shou J, Yan J. Enhanced store-operated calcium entry (SOCE) exacerbates motor neurons apoptosis following spinal cord injury. Gen Physiol Biophys. 2021;40:61\u20139.","journal-title":"Gen Physiol Biophys"},{"key":"1632_CR39","first-page":"a74","volume":"8","author":"PN Desai","year":"2015","unstructured":"Desai PN, Zhang X, Wu S, Janoshazi A, Bolimuntha S, Putney JW, Trebak M. Multiple types of calcium channels arising from alternative translation initiation of the Orai1 message. Sci Signal. 2015;8:a74.","journal-title":"Sci Signal"},{"key":"1632_CR40","doi-asserted-by":"crossref","first-page":"19471","DOI":"10.1038\/s41598-023-46946-8","volume":"13","author":"I Jardin","year":"2023","unstructured":"Jardin I, Alvarado S, Jimenez-Velarde V, Nieto-Felipe J, Lopez JJ, Salido GM, Smani T, Rosado JA. Orai1alpha and Orai1beta support calcium entry and mammosphere formation in breast cancer stem cells. Sci Rep. 2023;13:19471.","journal-title":"Sci Rep"},{"key":"1632_CR41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18097\/pbmc20216701017","volume":"67","author":"VV Grigoriev","year":"2021","unstructured":"Grigoriev VV. Calcium-activated chloride channels: structure, properties, role in physiological and pathological processes. Biomed Khim. 2021;67:17\u201333.","journal-title":"Biomed Khim"},{"key":"1632_CR42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0959-4388(98)80056-1","volume":"8","author":"C Vergara","year":"1998","unstructured":"Vergara C, Latorre R, Marrion NV, Adelman JP. Calcium-activated potassium channels. Curr Opin Neurobiol. 1998;8:321\u20139.","journal-title":"Curr Opin Neurobiol"},{"key":"1632_CR43","doi-asserted-by":"crossref","first-page":"116573","DOI":"10.1016\/j.bcp.2024.116573","volume":"230","author":"HVN Thi","year":"2024","unstructured":"Thi HVN, Hyun NJ. Intermediate conductance calcium-activated potassium channel (KCa3.1) in cancer: emerging roles and therapeutic potentials. Biochem Pharmacol. 2024;230:116573.","journal-title":"Biochem Pharmacol"},{"key":"1632_CR44","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.0808115105","volume":"105","author":"M Bayrhuber","year":"2008","unstructured":"Bayrhuber M, Meins T, Habeck M, Becker S, Giller K, Villinger S, Vonrhein C, Griesinger C, Zweckstetter M, Zeth K. Structure of the human voltage-dependent anion channel. Proc Natl Acad Sci USA. 2008;105:15370\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1632_CR45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41586-020-2309-6","volume":"582","author":"M Fan","year":"2020","unstructured":"Fan M, Zhang J, Tsai CW, Orlando BJ, Rodriguez M, Xu Y, Liao M, Tsai MF, Feng L. Structure and mechanism of the mitochondrial Ca(2+) uniporter holocomplex. Nature. 2020;582:129\u201333.","journal-title":"Nature"},{"key":"1632_CR46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s44318-023-00013-0","volume":"43","author":"Y Dong","year":"2024","unstructured":"Dong Y, Yu Z, Li Y, Huang B, Bai Q, Gao Y, Chen Q, Li N, He L, Zhao Y. Structural insight into the allosteric inhibition of human sodium-calcium exchanger NCX1 by XIP and SEA0400. EMBO J. 2024;43:14\u201331.","journal-title":"EMBO J"},{"key":"1632_CR47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cell.2008.08.006","volume":"135","author":"PB Stathopulos","year":"2008","unstructured":"Stathopulos PB, Zheng L, Li GY, Plevin MJ, Ikura M. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell. 2008;135:110\u201322.","journal-title":"Cell"},{"key":"1632_CR48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1073\/pnas.1015125108","volume":"108","author":"L Zheng","year":"2011","unstructured":"Zheng L, Stathopulos PB, Schindl R, Li GY, Romanin C, Ikura M. Auto-inhibitory role of the EF-SAM domain of STIM proteins in store-operated calcium entry. Proc Natl Acad Sci USA. 2011;108:1337\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1632_CR49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.1190414","volume":"329","author":"P Yuan","year":"2010","unstructured":"Yuan P, Leonetti MD, Pico AR, Hsiung Y, MacKinnon R. Structure of the human BK channel Ca2+-activation apparatus at 3.0 A resolution. Science. 2010;329:182\u20136.","journal-title":"Science"},{"key":"1632_CR50","doi-asserted-by":"crossref","first-page":"116415","DOI":"10.1016\/j.taap.2023.116415","volume":"462","author":"J Li","year":"2023","unstructured":"Li J, Liu X, Chen L, Zhu X, Yu Z, Dong L, Zhao X, Zou H, Wei Q, Feng Y, Zhu Y, Chai K, Li Q, Li M. Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis. Toxicol Appl Pharmacol. 2023;462:116415.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1632_CR51","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.tjnut.2023.03.011","volume":"153","author":"Y Takata","year":"2023","unstructured":"Takata Y, Yang JJ, Yu D, Smith-Warner SA, Blot WJ, White E, Robien K, Prizment A, Wu K, Sawada N, Lan Q, Park Y, Gao YT, Cai Q, Song M, Zhang X, Pan K, Agudo A, Panico S, Liao LM, Tsugane S, Chlebowski RT, Nost TH, Schulze MB, Johannson M, Zheng W, Shu XO. Calcium intake and lung cancer risk: a pooled analysis of 12 prospective cohort studies. J Nutr. 2023;153:2051\u201360.","journal-title":"J Nutr"},{"key":"1632_CR52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3892\/ijo.2023.5530","volume":"63","author":"Y Miao","year":"2023","unstructured":"Miao Y, Wang X, Lai Y, Huang Y, Yin H, Meng X, Liu H, Hou R, Lin W, Zhang X, Zhang X, Chai BC, Zhang F, Guo L, Yang S. Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma. Int J Oncol. 2023;63:82.","journal-title":"Int J Oncol"},{"key":"1632_CR53","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1245\/s10434-023-14084-0","volume":"30","author":"A Shiozaki","year":"2023","unstructured":"Shiozaki A, Fukami T, Shimizu H, Kosuga T, Kudou M, Takemoto K, Katsurahara K, Nishibeppu K, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Otsuji E. Effects of TRPV2 on the expression of PD-L1 and its binding ability to PD-1 in gastric cancer. Ann Surg Oncol. 2023;30:8704\u201316.","journal-title":"Ann Surg Oncol"},{"key":"1632_CR54","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1111\/bph.16497","volume":"181","author":"O Lopez-Charcas","year":"2024","unstructured":"Lopez-Charcas O, Benouna O, Lemoine R, Rosendo-Pineda MJ, Anguheven-Ledezma TG, Sandoval-Vazquez L, Gallegos-Gomez ML, Robles-Martinez L, Herrera-Carrillo Z, Ramirez-Aragon M, Alfaro A, Chadet S, Ferro F, Besson P, Jiang LH, Velu SE, Guerrero-Hernandez A, Roger S, Gomora JC. Blockade of Ca(V)3 calcium channels and induction of G(0)\/G(1) cell cycle arrest in colon cancer cells by gossypol. Br J Pharmacol. 2024;181:4546\u201370.","journal-title":"Br J Pharmacol"},{"key":"1632_CR55","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.3390\/cancers14235932","volume":"14","author":"B Dewdney","year":"2022","unstructured":"Dewdney B, Ursich L, Fletcher EV, Johns TG. Anoctamins and calcium signalling: an obstacle to EGFR targeted therapy in glioblastoma? Cancers (Basel). 2022;14:5932.","journal-title":"Cancers (Basel)"},{"key":"1632_CR56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41585-023-00738-x","volume":"20","author":"R Silvestri","year":"2023","unstructured":"Silvestri R, Nicoli V, Gangadharannambiar P, Crea F, Bootman MD. Calcium signalling pathways in prostate cancer initiation and progression. Nat Rev Urol. 2023;20:524\u201343.","journal-title":"Nat Rev Urol"},{"key":"1632_CR57","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1158\/1541-7786.MCR-19-0429","volume":"17","author":"W Wang","year":"2019","unstructured":"Wang W, Yu S, Huang S, Deng R, Ding Y, Wu Y, Li X, Wang A, Wang S, Chen W, Lu Y. A complex role for calcium signaling in colorectal cancer development and progression. Mol Cancer Res. 2019;17:2145\u201353.","journal-title":"Mol Cancer Res"},{"key":"1632_CR58","doi-asserted-by":"crossref","first-page":"114074","DOI":"10.1016\/j.biopha.2022.114074","volume":"158","author":"S Bai","year":"2023","unstructured":"Bai S, Wei Y, Liu R, Chen Y, Ma W, Wang M, Chen L, Luo Y, Du J. The role of transient receptor potential channels in metastasis. Biomed Pharmacother. 2023;158:114074.","journal-title":"Biomed Pharmacother"},{"key":"1632_CR59","doi-asserted-by":"crossref","first-page":"151955","DOI":"10.1016\/j.acthis.2022.151955","volume":"124","author":"X Li","year":"2022","unstructured":"Li X, Li H, Li Z, Wang T, Yu D, Jin H, Cao Y. TRPV3 promotes the angiogenesis through HIF-1alpha-VEGF signaling pathway in A549 cells. Acta Histochem. 2022;124:151955.","journal-title":"Acta Histochem"},{"key":"1632_CR60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/onc.2011.231","volume":"31","author":"PA Fiorio","year":"2012","unstructured":"Fiorio PA, Ong HL, Cheng KT, Brossa A, Bussolati B, Lockwich T, Paria B, Munaron L, Ambudkar IS. TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling. Oncogene. 2012;31:200\u201312.","journal-title":"Oncogene"},{"key":"1632_CR61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/onc.2015.83","volume":"35","author":"RK Adapala","year":"2016","unstructured":"Adapala RK, Thoppil RJ, Ghosh K, Cappelli HC, Dudley AC, Paruchuri S, Keshamouni V, Klagsbrun M, Meszaros JG, Chilian WM, Ingber DE, Thodeti CK. Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene. 2016;35:314\u201322.","journal-title":"Oncogene"},{"key":"1632_CR62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.14715\/cmb\/2023.69.14.39","volume":"69","author":"F Awla","year":"2023","unstructured":"Awla F, Othman G. Association of Orai1 and Peizo1 genes expression with cellular proliferation, metastasis and angiogenesis biomarkers in colon tumor biopsies of CRC patients. Cell Mol Biol (Noisy-le-grand). 2023;69:232\u20136.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1632_CR63","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.3390\/ijms22158188","volume":"22","author":"C Van den Eynde","year":"2021","unstructured":"Van den Eynde C, De Clercq K, Vriens J. Transient receptor potential channels in the epithelial-to-mesenchymal transition. Int J Mol Sci. 2021;22:8188.","journal-title":"Int J Mol Sci"},{"key":"1632_CR64","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/febs.16021","volume":"289","author":"D Pedri","year":"2022","unstructured":"Pedri D, Karras P, Landeloos E, Marine JC, Rambow F. Epithelial-to-mesenchymal-like transition events in melanoma. FEBS J. 2022;289:1352\u201368.","journal-title":"FEBS J"},{"key":"1632_CR65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12079-021-00655-x","volume":"16","author":"A Hernandez-Oliveras","year":"2022","unstructured":"Hernandez-Oliveras A, Zarain-Herzberg A. Expression and associated epigenetic mechanisms of the Ca(2+)-signaling genes in breast cancer subtypes and epithelial-to-mesenchymal transition. J Cell Commun Signal. 2022;16:461\u201374.","journal-title":"J Cell Commun Signal"},{"key":"1632_CR66","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1242\/jcs.196659","volume":"130","author":"I Azimi","year":"2017","unstructured":"Azimi I, Milevskiy M, Kaemmerer E, Turner D, Yapa K, Brown MA, Thompson EW, Roberts-Thomson SJ, Monteith GR. TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells. J Cell Sci. 2017;130:2292\u2013305.","journal-title":"J Cell Sci"},{"key":"1632_CR67","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cbin.10963","volume":"42","author":"P Ge","year":"2018","unstructured":"Ge P, Wei L, Zhang M, Hu B, Wang K, Li Y, Liu S, Wang J, Li Y. TRPC1\/3\/6 inhibition attenuates the TGF-beta1-induced epithelial-mesenchymal transition in gastric cancer via the Ras\/Raf1\/ERK signaling pathway. Cell Biol Int. 2018;42:975\u201384.","journal-title":"Cell Biol Int"},{"key":"1632_CR68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-019-1061-y","volume":"38","author":"L Liu","year":"2019","unstructured":"Liu L, Wu N, Wang Y, Zhang X, Xia B, Tang J, Cai J, Zhao Z, Liao Q, Wang J. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K \/ AKT oncogenic signaling. J Exp Clin Cancer Res. 2019;38:106.","journal-title":"J Exp Clin Cancer Res"},{"key":"1632_CR69","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.3390\/ijms21249417","volume":"21","author":"I Azimi","year":"2020","unstructured":"Azimi I, Robitaille M, Armitage K, So CL, Milevskiy M, Northwood K, Lim HF, Thompson EW, Roberts-Thomson SJ, Monteith GR. Activation of the ion channel TRPV4 induces epithelial to mesenchymal transition in breast cancer cells. Int J Mol Sci. 2020;21:9417.","journal-title":"Int J Mol Sci"},{"key":"1632_CR70","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1038\/s41598-020-71645-z","volume":"10","author":"T Karki","year":"2020","unstructured":"Karki T, Rajakyla EK, Acheva A, Tojkander S. TRPV6 calcium channel directs homeostasis of the mammary epithelial sheets and controls epithelial mesenchymal transition. Sci Rep. 2020;10:14683.","journal-title":"Sci Rep"},{"key":"1632_CR71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12860-022-00440-7","volume":"23","author":"W Xin","year":"2022","unstructured":"Xin W, Zhang J, Zhang H, Ma X, Zhang Y, Li Y, Wang F. CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK\/JNK\/p38-MAPK signaling pathways. BMC Mol Cell Biol. 2022;23:44.","journal-title":"BMC Mol Cell Biol"},{"key":"1632_CR72","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.12659\/MSM.914195","volume":"25","author":"H Chen","year":"2019","unstructured":"Chen H, Liu Y, Jiang CJ, Chen YM, Li H, Liu QA. Calcium-activated chloride channel A4 (CLCA4) plays inhibitory roles in invasion and migration through suppressing epithelial-mesenchymal transition via PI3K\/AKT signaling in colorectal cancer. Med Sci Monit. 2019;25:4176\u201385.","journal-title":"Med Sci Monit"},{"key":"1632_CR73","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s13402-021-00642-9","volume":"44","author":"W Xue","year":"2021","unstructured":"Xue W, Dong B, Zhao Y, Wang Y, Yang C, Xie Y, Niu Z, Zhu C. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt\/beta-catenin signaling and inhibits apoptosis in cholangiocarcinoma. Cell Oncol (Dordr). 2021;44:1351\u201361.","journal-title":"Cell Oncol (Dordr)"},{"key":"1632_CR74","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.21037\/tau-21-332","volume":"10","author":"S Chen","year":"2021","unstructured":"Chen S, Wang C, Su X, Dai X, Li S, Mo Z. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma. Transl Androl Urol. 2021;10:2454\u201370.","journal-title":"Transl Androl Urol"},{"key":"1632_CR75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.ctm.2023.09.001","volume":"92","author":"MA Erdogan","year":"2023","unstructured":"Erdogan MA, Ugo D, Ines F. The role of ion channels in the relationship between the immune system and cancer. Curr Top Membr. 2023;92:151\u201398.","journal-title":"Curr Top Membr"},{"key":"1632_CR76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12038-022-00279-2","volume":"47","author":"PS Kumar","year":"2022","unstructured":"Kumar PS, Mukherjee T, Khamaru S, Radhakrishnan A, Nanda-Kishore DJ, Chawla S, Sahoo SS, Chattopadhyay S. Elevation of TRPV1 expression on T-cells during experimental immunosuppression. J Biosci. 2022;47:42.","journal-title":"J Biosci"},{"key":"1632_CR77","doi-asserted-by":"crossref","first-page":"102760","DOI":"10.1016\/j.ceca.2023.102760","volume":"113","author":"C Bantsimba-Malanda","year":"2023","unstructured":"Bantsimba-Malanda C, Ahidouch A, Rodat-Despoix L, Ouadid-Ahidouch H. Calcium signal modulation in breast cancer aggressiveness. Cell Calcium. 2023;113:102760.","journal-title":"Cell Calcium"},{"key":"1632_CR78","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-023-38128-x","volume":"14","author":"T Li","year":"2023","unstructured":"Li T, Jiang S, Zhang Y, Luo J, Li M, Ke H, Deng Y, Yang T, Sun X, Chen H. Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation. Nat Commun. 2023;14:2498.","journal-title":"Nat Commun"},{"key":"1632_CR79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/cbin.11483","volume":"45","author":"TK Acharya","year":"2021","unstructured":"Acharya TK, Tiwari A, Majhi RK, Goswami C. TRPM8 channel augments T-cell activation and proliferation. Cell Biol Int. 2021;45:198\u2013210.","journal-title":"Cell Biol Int"},{"key":"1632_CR80","doi-asserted-by":"crossref","first-page":"1002487","DOI":"10.3389\/fncel.2022.1002487","volume":"16","author":"F Massenzio","year":"2022","unstructured":"Massenzio F, Cambiaghi M, Marchiotto F, Boriero D, Limatola C, D\u2019Alessandro G, Buffelli M. In vivo morphological alterations of TAMs during KCa3.1 inhibition-by using in vivo two-photon time-lapse technology. Front Cell Neurosci. 2022;16:1002487.","journal-title":"Front Cell Neurosci"},{"key":"1632_CR81","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.3390\/ijms23158603","volume":"23","author":"S Ohya","year":"2022","unstructured":"Ohya S, Matsui M, Kajikuri J, Kito H, Endo K. Downregulation of IL-8 and IL-10 by the activation of Ca(2+)-activated K(+) channel K(Ca)3.1 in THP-1-derived M(2) macrophages. Int J Mol Sci. 2022;23:8603.","journal-title":"Int J Mol Sci"},{"key":"1632_CR82","doi-asserted-by":"crossref","first-page":"14736","DOI":"10.3390\/ijms241914736","volume":"24","author":"F Scopelliti","year":"2023","unstructured":"Scopelliti F, Dimartino V, Cattani C, Cavani A. Functional TRPA1 channels regulate CD56(dim)CD16(+) NK cell cytotoxicity against tumor cells. Int J Mol Sci. 2023;24:14736.","journal-title":"Int J Mol Sci"},{"key":"1632_CR83","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/cells12162065","volume":"12","author":"M Olivas-Aguirre","year":"2023","unstructured":"Olivas-Aguirre M, Cruz-Aguilar LH, Pottosin I, Dobrovinskaya O. Reduction of Ca(2+) entry by a specific block of KCa31 channels optimizes cytotoxic activity of NK cells against T-ALL jurkat cells. Cells. 2023;12:2065.","journal-title":"Cells"},{"key":"1632_CR84","doi-asserted-by":"crossref","first-page":"e12279","DOI":"10.1002\/jev2.12279","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Li J, Zhang R, Zhang Y, Wang X, Leung EL, Ma L, Wong V, Liu L, Neher E, Yu H. Suppression of PD-L1 release from small extracellular vesicles promotes systemic anti-tumor immunity by targeting ORAI1 calcium channels. J Extracell Vesicles. 2022;11:e12279.","journal-title":"J Extracell Vesicles"},{"key":"1632_CR85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fmolb.2020.00079","volume":"7","author":"AP Thankamony","year":"2020","unstructured":"Thankamony AP, Saxena K, Murali R, Jolly MK, Nair R. Cancer stem cell plasticity - a deadly deal. Front Mol Biosci. 2020;7:79.","journal-title":"Front Mol Biosci"},{"key":"1632_CR86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ceca.2019.05.006","volume":"81","author":"D O'Reilly","year":"2019","unstructured":"O\u2019Reilly D, Buchanan P. Calcium channels and cancer stem cells. Cell Calcium. 2019;81:21\u20138.","journal-title":"Cell Calcium"},{"key":"1632_CR87","doi-asserted-by":"crossref","first-page":"113347","DOI":"10.1016\/j.celrep.2023.113347","volume":"42","author":"D Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay D, Goel HL, Xiong C, Goel S, Kumar A, Li R, Zhu LJ, Clark JL, Brehm MA, Mercurio AM. The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin alpha6 mRNA splicing. Cell Rep. 2023;42:113347.","journal-title":"Cell Rep"},{"key":"1632_CR88","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3390\/ijms23041967","volume":"23","author":"N Hirata","year":"2022","unstructured":"Hirata N, Yamada S, Yanagida S, Ono A, Yasuhiko Y, Nishida M, Kanda Y. Lysophosphatidic acid promotes the expansion of cancer stem cells via TRPC3 channels in triple-negative breast cancer. Int J Mol Sci. 2022;23:1967.","journal-title":"Int J Mol Sci"},{"key":"1632_CR89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13287-022-03017-5","volume":"13","author":"C Xue","year":"2022","unstructured":"Xue C, Gao Y, Li X, Zhang M, Yang Y, Han Q, Sun Z, Bai C, Zhao RC. Mesenchymal stem cells derived from adipose accelerate the progression of colon cancer by inducing a MT-CAFs phenotype via TRPC3\/NF-KB axis. Stem Cell Res Ther. 2022;13:335.","journal-title":"Stem Cell Res Ther"},{"key":"1632_CR90","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/cancers11030322","volume":"11","author":"G Santoni","year":"2019","unstructured":"Santoni G, Amantini C. The transient receptor potential vanilloid type-2(TRPV2) ion channels in neurogenesis and gliomagenesis: cross-talk between transcription factors and signaling molecules. Cancers (Basel). 2019;11:322.","journal-title":"Cancers (Basel)"},{"key":"1632_CR91","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00535-017-1338-x","volume":"53","author":"A Shiozaki","year":"2018","unstructured":"Shiozaki A, Kudou M, Ichikawa D, Fujiwara H, Shimizu H, Ishimoto T, Arita T, Kosuga T, Konishi H, Komatsu S, Okamoto K, Marunaka Y, Otsuji E. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor. J Gastroenterol. 2018;53:197\u2013207.","journal-title":"J Gastroenterol"},{"key":"1632_CR92","doi-asserted-by":"crossref","first-page":"e55069","DOI":"10.15252\/embr.202255069","volume":"24","author":"KF Shoji","year":"2023","unstructured":"Shoji KF, Bayet E, Leverrier-Penna S, Le Devedec D, Mallavialle A, Marionneau-Lambot S, Rambow F, Perret R, Joussaume A, Viel R, Fautrel A, Khammari A, Constantin B, Tartare-Deckert S, Penna A. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential. EMBO Rep. 2023;24:e55069.","journal-title":"EMBO Rep"},{"key":"1632_CR93","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.biopha.2018.06.029","volume":"105","author":"Z Hu","year":"2018","unstructured":"Hu Z, Cao X, Fang Y, Liu G, Xie C, Qian K, Lei X, Cao Z, Du H, Cheng X, Xu X. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer. Biomed Pharmacother. 2018;105:697\u2013706.","journal-title":"Biomed Pharmacother"},{"key":"1632_CR94","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/cells10082052","volume":"10","author":"G Santoni","year":"2021","unstructured":"Santoni G, Nabissi M, Amantini C, Santoni M, Ricci-Vitiani L, Pallini R, Maggi F, Morelli MB. ERK phosphorylation regulates the Aml1\/Runx1 splice variants and the TRP channels expression during the differentiation of glioma stem cell lines. Cells. 2021;10:2052.","journal-title":"Cells"},{"key":"1632_CR95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13046-020-01707-7","volume":"39","author":"N Gao","year":"2020","unstructured":"Gao N, Yang F, Chen S, Wan H, Zhao X, Dong H. The role of TRPV1 ion channels in the suppression of gastric cancer development. J Exp Clin Cancer Res. 2020;39:206.","journal-title":"J Exp Clin Cancer Res"},{"key":"1632_CR96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/physrev.00044.2016","volume":"98","author":"N Prevarskaya","year":"2018","unstructured":"Prevarskaya N, Skryma R, Shuba Y. Ion channels in cancer: are cancer hallmarks oncochannelopathies? Physiol Rev. 2018;98:559\u2013621.","journal-title":"Physiol Rev"},{"key":"1632_CR97","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-16-2347","volume":"77","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Cruickshanks N, Yuan F, Wang B, Pahuski M, Wulfkuhle J, Gallagher I, Koeppel AF, Hatef S, Papanicolas C, Lee J, Bar EE, Schiff D, Turner SD, Petricoin EF, Gray LS, Abounader R. Targetable T-type calcium channels drive glioblastoma. Cancer Res. 2017;77:3479\u201390.","journal-title":"Cancer Res"},{"key":"1632_CR98","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3390\/ijms21072327","volume":"21","author":"H Lee","year":"2020","unstructured":"Lee H, Kim JW, Kim DK, Choi DK, Lee S, Yu JH, Kwon OB, Lee J, Lee DS, Kim JH, Min SH. Calcium channels as novel therapeutic targets for ovarian cancer stem cells. Int J Mol Sci. 2020;21:2327.","journal-title":"Int J Mol Sci"},{"key":"1632_CR99","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1158\/0008-5472.CAN-16-2274","volume":"77","author":"M Niklasson","year":"2017","unstructured":"Niklasson M, Maddalo G, Sramkova Z, Mutlu E, Wee S, Sekyrova P, Schmidt L, Fritz N, Dehnisch I, Kyriatzis G, Krafcikova M, Carson BB, Feenstra JM, Marinescu VD, Segerman A, Haraldsson M, Gustavsson AL, Hammarstrom LG, Jenmalm JA, Uhrbom L, Altelaar AF, Linnarsson S, Uhlen P, Trantirek L, Vincent CT, Nelander S, Enger PO, Andang M. Membrane-depolarizing channel blockers induce selective glioma cell death by impairing nutrient transport and unfolded protein\/amino acid responses. Cancer Res. 2017;77:1741\u201352.","journal-title":"Cancer Res"},{"key":"1632_CR100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2019.05.038","volume":"44","author":"S Sharma","year":"2019","unstructured":"Sharma S, Wu SY, Jimenez H, Xing F, Zhu D, Liu Y, Wu K, Tyagi A, Zhao D, Lo HW, Metheny-Barlow L, Sun P, Bourland JD, Chan MD, Thomas A, Barbault A, D\u2019Agostino RB, Whitlow CT, Kirchner V, Blackman C, Pasche B, Watabe K. Ca(2+) and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF. EBioMedicine. 2019;44:194\u2013208.","journal-title":"EBioMedicine"},{"key":"1632_CR101","doi-asserted-by":"crossref","first-page":"e13305","DOI":"10.1111\/cpr.13305","volume":"55","author":"S Li","year":"2022","unstructured":"Li S, Kim HY, Lee DJ, Park SH, Otsu K, Harada H, Jung YS, Jung HS. Inhibition of L-type voltage-gated calcium channel-mediated Ca(2+) influx suppresses the collective migration and invasion of ameloblastoma. Cell Prolif. 2022;55:e13305.","journal-title":"Cell Prolif"},{"key":"1632_CR102","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00535-024-02095-x","volume":"59","author":"H Inoue","year":"2024","unstructured":"Inoue H, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Arita T, Konishi H, Komatsu S, Kuriu Y, Kubota T, Fujiwara H, Morinaga Y, Konishi E, Otsuji E. CACNA2D1 regulates the progression and influences the microenvironment of colon cancer. J Gastroenterol. 2024;59:556\u201371.","journal-title":"J Gastroenterol"},{"key":"1632_CR103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/CBM-203165","volume":"31","author":"M Li","year":"2021","unstructured":"Li M, Zhang W, Yang X, An G, Zhao W. The alpha2delta1 subunit of the voltage-gated calcium channel acts as a potential candidate for breast cancer tumor initial cells biomarker. Cancer Biomark. 2021;31:295\u2013305.","journal-title":"Cancer Biomark"},{"key":"1632_CR104","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41419-021-03522-0","volume":"12","author":"Y Ma","year":"2021","unstructured":"Ma Y, Yang X, Zhao W, Yang Y, Zhang Z. Calcium channel alpha2delta1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer. Cell Death Dis. 2021;12:257.","journal-title":"Cell Death Dis"},{"key":"1632_CR105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcmgh.2022.10.006","volume":"15","author":"J Liu","year":"2023","unstructured":"Liu J, Tao M, Zhao W, Song Q, Yang X, Li M, Zhang Y, Xiu D, Zhang Z. Calcium channel alpha2delta1 is essential for pancreatic tumor-initiating cells through sequential phosphorylation of PKM2. Cell Mol Gastroenterol Hepatol. 2023;15:373\u201392.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1632_CR106","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-17-1932","volume":"24","author":"J Yu","year":"2018","unstructured":"Yu J, Wang S, Zhao W, Duan J, Wang Z, Chen H, Tian Y, Wang D, Zhao J, An T, Bai H, Wu M, Wang J. Mechanistic exploration of cancer stem cell marker voltage-dependent calcium channel alpha2delta1 subunit-mediated chemotherapy resistance in small-cell lung cancer. Clin Cancer Res. 2018;24:2148\u201358.","journal-title":"Clin Cancer Res"},{"key":"1632_CR107","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13287-024-03875-1","volume":"15","author":"D Zhuo","year":"2024","unstructured":"Zhuo D, Lei Z, Dong L, Chan A, Lin J, Jiang L, Qiu B, Jiang X, Tan Y, Yao X. Orai1 and Orai3 act through distinct signalling axes to promote stemness and tumorigenicity of breast cancer stem cells. Stem Cell Res Ther. 2024;15:256.","journal-title":"Stem Cell Res Ther"},{"key":"1632_CR108","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3390\/cells12182225","volume":"12","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Sung Y, Lee SH, Martin CE, Srikanth S, Chen W, Kang MK, Kim RH, Park NH, Gwack Y, Kim Y, Shin KH. Orai3 Calcium channel contributes to oral\/oropharyngeal cancer stemness through the elevation of ID1 expression. Cells. 2023;12:2225.","journal-title":"Cells"},{"key":"1632_CR109","doi-asserted-by":"crossref","first-page":"10496","DOI":"10.3390\/ijms231810496","volume":"23","author":"PK Biswas","year":"2022","unstructured":"Biswas PK, Kwak Y, Kim A, Seok J, Kwak HJ, Lee M, Dayem AA, Song K, Park JY, Park KS, Shin HJ, Cho SG. TTYH3 modulates bladder cancer proliferation and metastasis via FGFR1\/H-Ras\/A-Raf\/MEK\/ERK pathway. Int J Mol Sci. 2022;23:10496.","journal-title":"Int J Mol Sci"},{"key":"1632_CR110","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.3390\/ijms21218323","volume":"21","author":"S Patergnani","year":"2020","unstructured":"Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P, Giorgi C. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci. 2020;21:8323.","journal-title":"Int J Mol Sci"},{"key":"1632_CR111","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s12011-022-03125-6","volume":"200","author":"YC Kumbul","year":"2022","unstructured":"Kumbul YC, Naziroglu M. Paclitaxel promotes oxidative stress-mediated human laryngeal squamous tumor cell death through the stimulation of calcium and zinc signaling pathways: no synergic action of melatonin. Biol Trace Elem Res. 2022;200:2084\u201398.","journal-title":"Biol Trace Elem Res"},{"key":"1632_CR112","doi-asserted-by":"crossref","first-page":"746628","DOI":"10.3389\/fphar.2021.746628","volume":"12","author":"S Laurino","year":"2021","unstructured":"Laurino S, Mazzone P, Ruggieri V, Zoppoli P, Calice G, Lapenta A, Ciuffi M, Ignomirelli O, Vita G, Sgambato A, Russi S, Falco G. Cationic channel TRPV2 overexpression promotes resistance to cisplatin-induced apoptosis in gastric cancer cells. Front Pharmacol. 2021;12:746628.","journal-title":"Front Pharmacol"},{"key":"1632_CR113","doi-asserted-by":"crossref","first-page":"102554","DOI":"10.1016\/j.ceca.2022.102554","volume":"103","author":"D O'Reilly","year":"2022","unstructured":"O\u2019Reilly D, Downing T, Kouba S, Potier-Cartereau M, McKenna DJ, Vandier C, Buchanan PJ. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer. Cell Calcium. 2022;103:102554.","journal-title":"Cell Calcium"},{"key":"1632_CR114","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.2147\/CMAR.S176084","volume":"10","author":"X Sui","year":"2018","unstructured":"Sui X, Geng JH, Li YH, Zhu GY, Wang WH. Calcium channel alpha2delta1 subunit (CACNA2D1) enhances radioresistance in cancer stem-like cells in non-small cell lung cancer cell lines. Cancer Manag Res. 2018;10:5009\u201318.","journal-title":"Cancer Manag Res"},{"key":"1632_CR115","first-page":"79","volume":"121","author":"L Vecera","year":"2020","unstructured":"Vecera L, Gabrhelik T, Prasil P, Stourac P. The role of cannabinoids in the treatment of cancer. Bratisl Lek Listy. 2020;121:79\u201395.","journal-title":"Bratisl Lek Listy"},{"key":"1632_CR116","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/ijms25020969","volume":"25","author":"B Cretu","year":"2024","unstructured":"Cretu B, Zamfir A, Bucurica S, Scheau AE, Savulescu FI, Caruntu C, Caruntu A, Scheau C. Role of cannabinoids in oral cancer. Int J Mol Sci. 2024;25:969.","journal-title":"Int J Mol Sci"},{"key":"1632_CR117","doi-asserted-by":"crossref","first-page":"216243","DOI":"10.1016\/j.canlet.2023.216243","volume":"566","author":"S Kaur","year":"2023","unstructured":"Kaur S, Nathani A, Singh M. Exosomal delivery of cannabinoids against cancer. Cancer Lett. 2023;566:216243.","journal-title":"Cancer Lett"},{"key":"1632_CR118","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bmc.2018.11.040","volume":"27","author":"J De La Chapa","year":"2019","unstructured":"De La Chapa J, Valdez M, Ruiz FR, Gonzales K, Mitchell W, McHardy SF, Hart M, Polusani SR, Gonzales CB. Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types. Bioorg Med Chem. 2019;27:208\u201315.","journal-title":"Bioorg Med Chem"},{"key":"1632_CR119","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/molecules24050995","volume":"24","author":"MH Yang","year":"2019","unstructured":"Yang MH, Jung SH, Sethi G, Ahn KS. Pleiotropic pharmacological actions of capsazepine, a synthetic analogue of capsaicin, against various cancers and inflammatory diseases. Molecules. 2019;24:995.","journal-title":"Molecules"},{"key":"1632_CR120","doi-asserted-by":"crossref","first-page":"114168","DOI":"10.1016\/j.biopha.2022.114168","volume":"158","author":"M Sadrkhanloo","year":"2023","unstructured":"Sadrkhanloo M, Paskeh M, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K. STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions. Biomed Pharmacother. 2023;158:114168.","journal-title":"Biomed Pharmacother"},{"key":"1632_CR121","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41419-024-06809-0","volume":"15","author":"A Haustrate","year":"2024","unstructured":"Haustrate A, Cordier C, Shapovalov G, Mihalache A, Desruelles E, Soret B, Essonghe NC, Spriet C, Yassine M, Barras A, Marines J, Alcaraz LB, Szunerits S, Robin G, Gosset P, Prevarskaya N, Lehen\u2019Kyi V. Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression. Cell Death Dis. 2024;15:419.","journal-title":"Cell Death Dis"},{"key":"1632_CR122","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.3390\/ijms21197379","volume":"21","author":"H Lee","year":"2020","unstructured":"Lee H, Kim JW, Lee DS, Min SH. Combined poziotinib with manidipine treatment suppresses ovarian cancer stem-cell proliferation and stemness. Int J Mol Sci. 2020;21:7379.","journal-title":"Int J Mol Sci"},{"key":"1632_CR123","first-page":"1607","volume":"13","author":"S Zhang","year":"2023","unstructured":"Zhang S, Kim D, Park M, Yin JH, Park J, Chung YJ. Suppression of metastatic ovarian cancer cells by bepridil, a calcium channel blocker. Life (Basel). 2023;13:1607.","journal-title":"Life (Basel)"},{"key":"1632_CR124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41389-022-00423-5","volume":"11","author":"YC Chen","year":"2022","unstructured":"Chen YC, Wu CT, Chen JH, Tsai CF, Wu CY, Chang PC, Yeh WL. Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition. Oncogenesis. 2022;11:48.","journal-title":"Oncogenesis"},{"key":"1632_CR125","doi-asserted-by":"crossref","first-page":"113063","DOI":"10.1016\/j.biopha.2022.113063","volume":"150","author":"J Li","year":"2022","unstructured":"Li J, Qu P, Zhou XZ, Ji YX, Yuan S, Liu SP, Zhang QG. Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway. Biomed Pharmacother. 2022;150:113063.","journal-title":"Biomed Pharmacother"},{"key":"1632_CR126","doi-asserted-by":"crossref","first-page":"2302413","DOI":"10.1080\/15384047.2024.2302413","volume":"25","author":"G Jiang","year":"2024","unstructured":"Jiang G, Zhou X, Hu Y, Tan X, Wang D, Yang L, Zhang Q, Liu S. The antipsychotic drug pimozide promotes apoptosis through the RAF\/ERK pathway and enhances autophagy in breast cancer cells. Cancer Biol Ther. 2024;25:2302413.","journal-title":"Cancer Biol Ther"},{"key":"1632_CR127","doi-asserted-by":"crossref","first-page":"20230801","DOI":"10.1515\/med-2023-0801","volume":"18","author":"SY Liang","year":"2023","unstructured":"Liang SY, Xiao HK. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC. Open Med (Wars). 2023;18:20230801.","journal-title":"Open Med (Wars)"},{"key":"1632_CR128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4149\/neo_2024_230909N479","volume":"71","author":"Y Kong","year":"2024","unstructured":"Kong Y, Zhu W, Zhang Z, Sun W, Cui G, Chen H, Wang H. Fluspirilene exerts an anti-glioblastoma effect through suppression of the FOXM1-KIF20A axis. Neoplasma. 2024;71:333\u201346.","journal-title":"Neoplasma"},{"key":"1632_CR129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","volume":"68","author":"V Shaw","year":"2021","unstructured":"Shaw V, Srivastava S, Srivastava SK. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy. Semin Cancer Biol. 2021;68:75\u201383.","journal-title":"Semin Cancer Biol"},{"key":"1632_CR130","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fphar.2019.01517","volume":"10","author":"U Kim","year":"2019","unstructured":"Kim U, Kim CY, Lee JM, Ryu B, Kim J, Shin C, Park JH. Pimozide inhibits the human prostate cancer cells through the generation of reactive oxygen species. Front Pharmacol. 2019;10:1517.","journal-title":"Front Pharmacol"},{"key":"1632_CR131","doi-asserted-by":"crossref","first-page":"22092","DOI":"10.1038\/s41598-023-47199-1","volume":"13","author":"NH Du","year":"2023","unstructured":"Du NH, Ngoc T, Cang HQ, Luyen N, Thuoc TL, Le Quan T, Thao D. KTt-45, a T-type calcium channel blocker, acts as an anticancer agent by inducing apoptosis on HeLa cervical cancer cell line. Sci Rep. 2023;13:22092.","journal-title":"Sci Rep"},{"key":"1632_CR132","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41416-020-0751-8","volume":"122","author":"K Granados","year":"2020","unstructured":"Granados K, Huser L, Federico A, Sachindra S, Wolff G, Hielscher T, Novak D, Madrigal-Gamboa V, Sun Q, Vierthaler M, Larribere L, Umansky V, Utikal J. T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells. Br J Cancer. 2020;122:1023\u201336.","journal-title":"Br J Cancer"},{"key":"1632_CR133","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jid.2019.11.014","volume":"140","author":"C Barcelo","year":"2020","unstructured":"Barcelo C, Siso P, Maiques O, Garcia-Mulero S, Sanz-Pamplona R, Navaridas R, Megino C, Felip I, Urdanibia I, Eritja N, Soria X, Piulats JM, Penin RM, Dolcet X, Matias-Guiu X, Marti RM, Macia A. T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF(V600E) melanoma. J Invest Dermatol. 2020;140:1253\u201365.","journal-title":"J Invest Dermatol"},{"key":"1632_CR134","doi-asserted-by":"crossref","unstructured":"Dube CJ, Zhang Y, Saha S, Lai M, Gibert MK, Escalante M, Hudson K, Wong D, Marcinkiewicz P, Yener U, Sun Y, Xu E, Sorot A, Mulcahy E, Kefas B, Hanif F, Guessous F, Vernon A, Patel MK, Schiff D, Zong H, Purow B, Holland E, Sonkusare S, Sontheimer H, Abounader R. Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growth. bioRxiv. 2024","DOI":"10.1101\/2024.08.22.609229"},{"key":"1632_CR135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/neuonc\/nox020","volume":"19","author":"M Holdhoff","year":"2017","unstructured":"Holdhoff M, Ye X, Supko JG, Nabors LB, Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, Leal J, Fisher JD, Desideri S, Grossman SA, Wahl RL, Schiff D. Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas. Neuro Oncol. 2017;19:845\u201352.","journal-title":"Neuro Oncol"},{"key":"1632_CR136","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1007\/s12035-022-02771-0","volume":"59","author":"M Sedeeq","year":"2022","unstructured":"Sedeeq M, Maklad A, Dutta T, Feng Z, Wilson R, Gueven N, Azimi I. T-Type calcium channel inhibitors induce apoptosis in medulloblastoma cells associated with altered metabolic activity. Mol Neurobiol. 2022;59:2932\u201345.","journal-title":"Mol Neurobiol"},{"key":"1632_CR137","doi-asserted-by":"crossref","first-page":"118518","DOI":"10.1016\/j.lfs.2020.118518","volume":"262","author":"HA El-Mahdy","year":"2020","unstructured":"El-Mahdy HA, El-Husseiny AA, Kandil YI, Gamal EA. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. Life Sci. 2020;262:118518.","journal-title":"Life Sci"},{"key":"1632_CR138","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3390\/ijms20102423","volume":"20","author":"M Alhothali","year":"2019","unstructured":"Alhothali M, Mathew M, Iyer G, Lawrence HR, Yang S, Chellappan S, Padmanabhan J. Fendiline enhances the cytotoxic effects of therapeutic agents on PDAC cells by inhibiting tumor-promoting signaling events: a potential strategy to combat PDAC. Int J Mol Sci. 2019;20:2423.","journal-title":"Int J Mol Sci"},{"key":"1632_CR139","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3748\/wjg.v30.i4.367","volume":"30","author":"YM Chen","year":"2024","unstructured":"Chen YM, Yang WQ, Gu CW, Fan YY, Liu YZ, Zhao BS. Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress. World J Gastroenterol. 2024;30:367\u201380.","journal-title":"World J Gastroenterol"},{"key":"1632_CR140","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.21873\/anticanres.16682","volume":"43","author":"A Shiozaki","year":"2023","unstructured":"Shiozaki A, Kurashima K, Kudou M, Shimizu H, Kosuga T, Takemoto K, Arita T, Konishi H, Yamamoto Y, Morimura R, Komatsu S, Ikoma H, Kubota T, Fujiwara H, Otsuji E. Cancer stem cells of hepatocellular carcinoma are suppressed by the voltage-gated calcium channel inhibitor amlodipine. Anticancer Res. 2023;43:4855\u201364.","journal-title":"Anticancer Res"},{"key":"1632_CR141","doi-asserted-by":"crossref","first-page":"105152","DOI":"10.1016\/j.tiv.2021.105152","volume":"74","author":"P Panneerpandian","year":"2021","unstructured":"Panneerpandian P, Rao DB, Ganesan K. Calcium channel blockers lercanidipine and amlodipine inhibit YY1\/ERK\/TGF-beta mediated transcription and sensitize the gastric cancer cells to doxorubicin. Toxicol In Vitro. 2021;74:105152.","journal-title":"Toxicol In Vitro"},{"key":"1632_CR142","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1021\/acsptsci.3c00202","volume":"6","author":"K To","year":"2023","unstructured":"To K, Chow J, Cheung KM, Cho W. Circumvention of gefitinib resistance by repurposing flunarizine via histone deacetylase inhibition. ACS Pharmacol Transl Sci. 2023;6:1531\u201343.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1632_CR143","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.18632\/aging.202539","volume":"13","author":"J Shi","year":"2021","unstructured":"Shi J, Dong X, Li H, Wang H, Jiang Q, Liu L, Wang L, Dong J. Nicardipine sensitizes temozolomide by inhibiting autophagy and promoting cell apoptosis in glioma stem cells. Aging (Albany NY). 2021;13:6820\u201331.","journal-title":"Aging (Albany NY)"},{"key":"1632_CR144","doi-asserted-by":"crossref","first-page":"173756","DOI":"10.1016\/j.ejphar.2020.173756","volume":"892","author":"SH Chen","year":"2021","unstructured":"Chen SH, Chao CN, Chen SY, Lin HP, Huang HY, Fang CY. Flunarizine, a drug approved for treating migraine and vertigo, exhibits cytotoxicity in GBM cells. Eur J Pharmacol. 2021;892:173756.","journal-title":"Eur J Pharmacol"},{"key":"1632_CR145","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1080\/07391102.2020.1839558","volume":"40","author":"N Kumari","year":"2022","unstructured":"Kumari N, Dalal V, Kumar P, Rath SN. Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel. J Biomol Struct Dyn. 2022;40:2395\u2013406.","journal-title":"J Biomol Struct Dyn"},{"key":"1632_CR146","first-page":"996","volume":"4","author":"N Kumari","year":"2021","unstructured":"Kumari N, Giri PS, Rath SN. Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel. Cancer Drug Resist. 2021;4:996\u20131007.","journal-title":"Cancer Drug Resist"},{"key":"1632_CR147","doi-asserted-by":"crossref","first-page":"539261","DOI":"10.3389\/fphar.2020.539261","volume":"11","author":"X Pan","year":"2020","unstructured":"Pan X, Li R, Guo H, Zhang W, Xu X, Chen X, Ding L. Dihydropyridine calcium channel blockers suppress the transcription of PD-L1 by inhibiting the activation of STAT1. Front Pharmacol. 2020;11:539261.","journal-title":"Front Pharmacol"},{"key":"1632_CR148","doi-asserted-by":"crossref","first-page":"113695","DOI":"10.1016\/j.bcp.2019.113695","volume":"171","author":"B Chovancova","year":"2020","unstructured":"Chovancova B, Liskova V, Miklikova S, Hudecova S, Babula P, Penesova A, Sevcikova A, Durinikova E, Novakova M, Matuskova M, Krizanova O. Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment. Biochem Pharmacol. 2020;171:113695.","journal-title":"Biochem Pharmacol"},{"key":"1632_CR149","doi-asserted-by":"crossref","first-page":"108327","DOI":"10.1016\/j.celrep.2020.108327","volume":"33","author":"L Wu","year":"2020","unstructured":"Wu L, Lin W, Liao Q, Wang H, Lin C, Tang L, Lian W, Chen Z, Li K, Xu L, Zhou R, Ding Y, Zhao L. Calcium channel blocker nifedipine suppresses colorectal cancer progression and immune escape by preventing NFAT2 nuclear translocation. Cell Rep. 2020;33:108327.","journal-title":"Cell Rep"},{"key":"1632_CR150","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41416-023-02359-y","volume":"129","author":"X Li","year":"2023","unstructured":"Li X, Chen Y, Bai L, Zhao R, Wu Y, Xie ZR, Wu JM, Bowen NJ, Danaher A, Cook N, Li D, Qui M, Du Y, Fu H, Osunkoya AO, Kucuk O, Wu D. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. Br J Cancer. 2023;129:884\u201394.","journal-title":"Br J Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01632-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01632-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01632-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:48:25Z","timestamp":1764917305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01632-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01632-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"94"}}